WINOOSKI VT, USA – Several BioTek readers have just received official Promega DLReady™ certifications. Synergy™ Neo2, Cytation™ 5, Cytation 3,Synergy H1, Synergy 2 and Synergy HTX have all now met the stringent acceptance criteria. Promega’s Dual-Luciferase© Reporter System together with BioTek microplate readers demonstrate both companies’ common commitment to maximizing the success of life science researchers.

BioTek’s patented Hybrid and Multi-Mode microplate readers offer flexibility and ease of use over a broad range of applications. In the Hybrid reader line, Synergy H1 offers an unbeatable price / performance ratio, while Synergy Neo2 covers the broadest range of applications. In addition, Cytation Multi-Mode Readers are upgradable to add digital microscopy capability. BioTek’s multi-mode readers offer configurability to provide the most value for laboratory budgets. Synergy 2 and Synergy HTX offer modular features and outstanding specifications for performance and economy.

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. These technologies are used to aid life science research, facilitate drug discovery, provide rapid and cost-effective analysis, and enable sensitive, accurate quantification of molecules across diverse applications. BioTek espouses a “Think Possible” approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations. The company is frequently honored for local accomplishments and technological innovations, including Best Places to Work in Vermont, Frost & Sullivan North American New Product Innovation Award for Workflow Solutions in Life Sciences, SelectScience’s Drug Discovery Product of the Year – Scientists’ Choice Award, and a Silver Edison Award for the Cytation Cell Imaging Multi-Mode Reader.